UPDATE : Friday, June 5, 2020
Korea lags 3.8 years behind US in medical technology
There are technological gaps of 3.8 years in the medical area and 4.3 years...
by Nam Doo-hyun  |  2017-08-21 12:11
‘Bio industry should prepare for Nagoya Protocol’
As the Nagoya Protocol, an international agreement on using foreign biologi...
by Nam Doo-hyun  |  2017-08-17 19:57
Monsanto, ToolGen sign licensing agreement for CRISPR
ToolGen툴젠, a local genome engineering company, has signed a global license ...
by Constance Williams  |  2017-08-17 16:32
Medytox’s botulinum toxin hits record-high sales in Q2
The second-quarter sales of Medytox메디톡스, a local biopharmaceutical company,...
by Constance Williams  |  2017-08-16 10:29
Cha Biotech turns profitable 3 years after equity spinoff
Cha Biotech차바이오텍, the nation's largest stem-cell drug pipeline, turned ...
by Constance Williams  |  2017-08-14 16:34
‘Stress resilience research to open new bio area’
The research to develop stress resilience application technology could lead...
by Nam Doo-hyun  |  2017-08-14 16:33
Weak competitiveness hinders biomedicine export to China
Korea’s pharmaceutical companies should urgently strengthen their abilities...
by Nam Doo-hyun  |  2017-08-08 14:04
‘Biomedicine is 1 of 6 areas Korea, US leaders should tackle’
Biomedicine has emerged as one of six fields that President Moon Jae-in has...
by Nam Doo-hyun  |  2017-08-07 17:08
Medipost’s stem-cell therapy hits record-high sales
Medipost Co. announced Thursday that the monthly sales of its stem-cell tre...
by Constance Williams  |  2017-08-04 11:25
Celltrion’s biosimilar takes 30% of Europe market share
Celltrion’s second antibody biosimilar product in Europe, Truxima, has regi...
by Constance Williams  |  2017-08-01 16:31
5 universities publish most papers in prestigious bio journals
Which university has published the largest number of bio-related research p...
by Nam Doo-hyun  |  2017-08-01 16:18
Medipost hits record sales in Q2
Medipost announced record sales in the second quarter of 2017 and positive ...
by Marian Chu  |  2017-08-01 10:00
Celltrion applies for FDA approval of new anticancer biosimilar
Celltrion Healthcare is preparing to release its third biosimilar Herzuma i...
by Constance Williams  |  2017-07-31 15:04
Samsung Bioepis, Merck launches biosimilar in US
Samsung Bioepis will launch its autoimmune disease biosimilar Renflexis (in...
by Marian Chu  |  2017-07-25 11:27
Nature Cell to unveil stem cell drug for Alzheimer's disease
Biotechnology enterprise Nature Cell네이처셀 successfully administered “AstroSt...
by Constance Williams  |  2017-07-20 16:41
Sillajen wins approval to start clinical trial in China
The China Food and Drug Administration (CFDA) has given the green light to ...
by Marian Chu  |  2017-07-20 13:43
‘Stem cell therapy’s problem? No hit item yet’
Stem cells, which can be transplanted into a human body and differentiating...
by Nam Doo-hyun  |  2017-07-19 18:16
Smaller firms lead domestic stem cell market
Big businesses and small- to medium-sized enterprises (SMEs) account for 17...
by Nam Doo-hyun  |  2017-07-05 13:49
Janssen director points out flaws in Korean quality systems
“We need to provide a gap in quality systems and quality management for vac...
by Constance Williams  |  2017-06-30 17:09
David and Goliath; how Korean pharmaceuticals should compete with multinational giants
When foreign experts look at the Korean pharmaceutical industry, they wonde...
by Marian Chu  |  2017-06-29 09:44
Back to Top